UK markets open in 1 hour 25 minutes
NIKKEI 225
38,285.25 +11.20 (+0.03%) HANG SENG
18,172.83 +409.80 (+2.31%) CRUDE OIL
79.45 +0.45 (+0.57%) GOLD FUTURES
2,322.80 +11.80 (+0.51%) DOW
37,903.29 +87.37 (+0.23%) Bitcoin GBP
45,638.28 -2,210.17 (-4.62%)
NanoViricides, Inc. (NNVC)
NYSE American - NYSE American Delayed price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 1.2000 |
| Open | 1.2300 |
| Bid | 0.0000 x 1000 |
| Ask | 0.0000 x 800 |
| Day's range | 1.1300 - 1.2300 |
| 52-week range | 1.0000 - 2.0000 |
| Volume | |
| Avg. volume | 29,634 |
| Market cap | 13.31M |
| Beta (5Y monthly) | 0.70 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.8000 |
| Earnings date | 13 May 2024 - 17 May 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 6.50 |
ACCESSWIRENanoViricides Announces that Clinical Trials of Its Broad-Spectrum Antiviral Drug NV-CoV-2 Have Begun
NanoViricides, Inc. (NYSE American:NNVC) (the "Company") reports that clinical trials of its broad-spectrum antiviral drug NV-CoV-2 began on June 17, 2023 with two oral drug products: (i) NV-CoV-2 Oral Syrup, and (ii) NV-CoV-2 Oral Gummies.
© 2024 Yahoo. All rights reserved.